FDA Approves Second Over-the-Counter Naloxone Nasal Spray Product

FDA Approves Second Over-the-Counter Naloxone Nasal Spray Product

Upworthy

Published

Today, the U.S. Food and Drug Administration approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription use for the emergency treatment of known or suspected opioid overdose. This is the second nonprescription naloxone product the agency has…

#rivive #fda #robertmcaliff

Full Article